The Single‐GSEA results indicate that CD40 primarily upregulates processes such as purine and pyrimidine metabolism, DNA repair, CD22‐mediated BCR regulation, mitochondrial calcium ion transport, unfolded protein response (UPR), and adaptive immune regulation in RRMS patients. Here, CD22 is linked to relapsing-remitting multiple sclerosis.